Literature DB >> 23033271

S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis.

Nagaja Capitani1, Laura Patrussi, Livio Trentin, Orso Maria Lucherini, Enrica Cannizzaro, Enrica Migliaccio, Federica Frezzato, Cristina Gattazzo, Francesco Forconi, Piergiuseppe Pelicci, Gianpietro Semenzato, Cosima T Baldari.   

Abstract

Although intrinsic apoptosis defects are causal to the extended survival of chronic lymphocytic leukemia (CLL) B cells, several lines of evidence support a contribution of the peripheral lymphoid organs and BM microenvironment to the extended lifespan of leukemic B cells. Lymphocyte trafficking is controlled by homing signals provided by stromal cell-derived chemokines and egress signals provided by sphingosine-1-phosphate (S1P). In the present study, we show that expression of S1P1, the S1P receptor responsible for lymphocyte egress, is selectively reduced in CLL B cells with unmutated IGHV. Expression of S1P2, which controls B-cell homeostasis, is also impaired in CLL B cells but independently of the IGHV mutational status. We provide evidence herein that p66Shc, a Shc adaptor family member the deficiency of which is implicated in the apoptosis defects of CLL B cells, controls S1P1 expression through its pro-oxidant activity. p66Shc also controls the expression of the homing receptor CCR7, which opposes S1P1 by promoting lymphocyte retention in peripheral lymphoid organs. The results of the present study provide insights into the regulation of S1P1 expression in B cells and suggest that defective egress caused by impaired S1P1 expression contributes to the extended survival of CLL B cells by prolonging their residency in the prosurvival niche of peripheral lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23033271     DOI: 10.1182/blood-2012-04-425959

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  An update on the biology of sphingosine 1-phosphate receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  J Lipid Res       Date:  2014-01-23       Impact factor: 5.922

Review 2.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

Review 3.  S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.

Authors:  Narges Rostami; Afshin Nikkhoo; Amir Ajjoolabady; Gholamreza Azizi; Mohammad Hojjat-Farsangi; Ghasem Ghalamfarsa; Bahman Yousefi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

4.  p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes.

Authors:  Laura Patrussi; Nagaja Capitani; Francesca Cattaneo; Noemi Manganaro; Alessandra Gamberucci; Federica Frezzato; Veronica Martini; Andrea Visentin; Pier Giuseppe Pelicci; Mario M D'Elios; Livio Trentin; Gianpietro Semenzato; Cosima T Baldari
Journal:  Oncogene       Date:  2018-01-12       Impact factor: 9.867

Review 5.  C-C Chemokine Receptor 7 in Cancer.

Authors:  Colin A Bill; Christopher M Allen; Charlotte M Vines
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

6.  Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival.

Authors:  Chih-Hang Anthony Tang; Sujeewa Ranatunga; Crystina L Kriss; Christopher L Cubitt; Jianguo Tao; Javier A Pinilla-Ibarz; Juan R Del Valle; Chih-Chi Andrew Hu
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

7.  The pro-oxidant adaptor p66SHC promotes B cell mitophagy by disrupting mitochondrial integrity and recruiting LC3-II.

Authors:  Anna Onnis; Valentina Cianfanelli; Chiara Cassioli; Dijana Samardzic; Pier Giuseppe Pelicci; Francesco Cecconi; Cosima T Baldari
Journal:  Autophagy       Date:  2018-09-06       Impact factor: 16.016

8.  The small GTPase Rab29 is a common regulator of immune synapse assembly and ciliogenesis.

Authors:  A Onnis; F Finetti; L Patrussi; M Gottardo; C Cassioli; S Spanò; C T Baldari
Journal:  Cell Death Differ       Date:  2015-03-13       Impact factor: 15.828

9.  Specific recycling receptors are targeted to the immune synapse by the intraflagellar transport system.

Authors:  Francesca Finetti; Laura Patrussi; Giulia Masi; Anna Onnis; Donatella Galgano; Orso Maria Lucherini; Gregory J Pazour; Cosima T Baldari
Journal:  J Cell Sci       Date:  2014-02-19       Impact factor: 5.285

Review 10.  Exploring the pathways to chronic lymphocytic leukemia.

Authors:  Freda K Stevenson; Francesco Forconi; Thomas J Kipps
Journal:  Blood       Date:  2021-09-09       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.